Acute lymphoblastic leukaemia trials in Russia

In Russia 9 Also abroad 564

9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Asciminib Roll-over Study
Where
Moscow, Saint Petersburg
Age
7 years to 100 years
People
347 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00
Phase 2/3Taking people
Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies
Where
Moscow
Age
1 year to 25 years
People
64
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT07366801
Phase 2Taking people
Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation
Where
Moscow
Age
1 month to 25 years
People
15
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT07256210
Phase 2/3Taking people
Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis
Where
Moscow
Age
1 day to 21 years
People
50
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT06756152
No phaseNot yet taking people in Russia
An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders
Where
Moscow
Age
18 years to 71 years
People
60
Run by
National Research Center for Hematology, Russia
See details and how to joinNCT06721598
Phase 2Taking people
Vitamin A and D Supplementation in Allogeneic HCT
Where
Saint Petersburg
Age
18 years and over
People
220
Run by
St. Petersburg State Pavlov Medical University
See details and how to joinNCT06508099
Phase 3Taking people
Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)
Where
Moscow
Age
1 day to 365 days
People
80
Run by
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT05029531
Phase 2Taking people
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
Where
Saint Petersburg
Age
18 years to 75 years
People
220
Run by
St. Petersburg State Pavlov Medical University
See details and how to joinNCT06477549
No phaseTaking people
MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult Patients
Where
Moscow
Age
18 years to 55 years
People
200
Run by
National Research Center for Hematology, Russia
See details and how to joinNCT06237192